These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Stevens-Johnson syndrome and toxic epidermal necrolysis from pathologist's point of view. Sticová E, Kyclová J, Důra M, Štork J, Lipový B. Cesk Patol; 2023 Jun; 59(3):124-128. PubMed ID: 37805268 [Abstract] [Full Text] [Related]
16. Toxic epidermal necrolysis localized to an area of lymphoedema. Wilkinson SM, Heagerty AH, Smith AG. Clin Exp Dermatol; 1992 Nov; 17(6):456-7. PubMed ID: 1486718 [Abstract] [Full Text] [Related]
17. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report. Zizi N, Elmrahi A, Dikhaye S, Fihmi N, Alami Z. Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493 [Abstract] [Full Text] [Related]
19. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F. N Engl J Med; 1995 Dec 14; 333(24):1600-7. PubMed ID: 7477195 [Abstract] [Full Text] [Related]
20. Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus. Saiag P, Caumes E, Chosidow O, Revuz J, Roujeau JC. J Am Acad Dermatol; 1992 Apr 14; 26(4):567-74. PubMed ID: 1597543 [Abstract] [Full Text] [Related] Page: [Next] [New Search]